UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I

Gynecologic oncology, 2016-01, Vol.140 (1), p.8-14

2016

Volltextzugriff (PDF)

External validation of an all-stage ovarian cancer nomogram: Is BRCA status more predictive than family history?

Gynecologic oncology, 2014-06, Vol.133, p.9-10

2014

Volltextzugriff (PDF)

A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)

Gynecologic oncology, 2015-04, Vol.137, p.5-6

2015

Volltextzugriff (PDF)

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Annals of oncology, 2019-07, Vol.30 (7), p.1080-1087

2019

Volltextzugriff (PDF)

716MO Efficacy and safety of sacituzumab tirumotecan (sac-TMT) plus pembrolizumab in patients with recurrent or metastatic cervical cancer

Annals of oncology, 2024-09, Vol.35, p.S548-S549

2024

Volltextzugriff (PDF)

OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

Annals of oncology, 2018-02, Vol.29 (2), p.431-438

2018

Volltextzugriff (PDF)

Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer

Gynecologic oncology, 2023-03, Vol.170, p.221-228

2023

Volltextzugriff (PDF)

631P Phase Ib expansion study of CX-5461 in patients with solid tumours and BRCA2 and/or PALB2 mutation

Annals of oncology, 2024-09, Vol.35, p.S503-S503

2024

Volltextzugriff (PDF)

Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer

Gynecologic oncology, 2021-12, Vol.163 (3), p.465-472

2021

Volltextzugriff (PDF)

Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study

Annals of oncology, 2018-10, Vol.29, p.viii728-viii728

2018

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled multicenter phase 3 trial of niraparib maintenance treatment in patients with advanced ovarian cancer following frontline chemotherapy

Annals of oncology, 2017-09, Vol.28, p.v351-v351

2017

Volltextzugriff (PDF)

Phase II multicenter open‐label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies

International journal of gynecological cancer, 2005-09, Vol.15 (5), p.799-806

2005

Volltextzugriff (PDF)

Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib: Results from the ENGOT-OV16/NOVA Trial

Annals of oncology, 2017-09, Vol.28, p.v330-v330

2017

Volltextzugriff (PDF)

Safety and Efficacy of Niraparib in Elderly Patients (Pts) with Recurrent Ovarian Cancer (OC)

Annals of oncology, 2017-09, Vol.28, p.v332-v332

2017

Volltextzugriff (PDF)

The contribution of germline rearrangements to the spectrum of BRCA2 mutations

Journal of medical genetics, 2006-09, Vol.43 (9), p.e49-e49

2006

Volltextzugriff (PDF)

Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes

International journal of gynecological cancer, 2008-09, Vol.18 (5), p.963-975

2008

Volltextzugriff (PDF)

Vers un dépistage possible du cancer de l’ovaire ?

Journal de gynécologie, obstétrique et biologie de la reproduction, 2013-02, Vol.42 (1), p.5-11

2013

Volltextzugriff (PDF)

Comparison of Antigen Expression on Fresh and Cultured Ascites Cells and on Solid Tumors of Patients with Epithelial Ovarian Cancer

Gynecologic oncology, 1993-07, Vol.50 (1), p.78-83

1993

Volltextzugriff (PDF)

Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer

International journal of gynecology and obstetrics, 1994-05, Vol.45 (2), p.203-203

1994

Volltextzugriff (PDF)

Antigenic heterogeneity in epithelial ovarian (EOC) cancer

Gynecologic oncology, 1990-02, Vol.36 (2), p.294-294

1990

Volltextzugriff (PDF)

Comparison of antigenic expression on fresh ascitic epithelial cells (AEC), cultured AEC and solid tumors of patients with epithelial ovarian cancer (EOC)

Gynecologic oncology, 1990-02, Vol.36 (2), p.296-296

1990

Volltextzugriff (PDF)

Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy: A Non-randomized Study

Journal SOGC, 1999-09, Vol.21 (10), p.943-950

1999

Volltextzugriff (PDF)

An assessment of microplastics in fecal samples from polar bears ( Ursus maritimus ) in Canada's North

Arctic science, 2024-06, Vol.10 (2), p.409-423

2024

Volltextzugriff (PDF)

Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe

Gynecologic oncology, 2022-10, Vol.167 (1), p.3-10

2022

Volltextzugriff (PDF)

833P Mirvetuximab soravtansine (MIRV), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin (CARBO) and bevacizumab (BEV): Final results from a study in patients (pts) with recurrent platinum sensitive ovarian cancer

Annals of oncology, 2020-09, Vol.31, p.S626-S627

2020

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(28)

Sprache

Englisch
(27)
Französisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Sentinel nodes in vulvar cancer: Long-term follow-up of the GROningen INternational Study on Sentinel nodes in Vulvar cancer (GROINSS-V) I

External validation of an all-stage ovarian cancer nomogram: Is BRCA status more predictive than family history?

A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

716MO Efficacy and safety of sacituzumab tirumotecan (sac-TMT) plus pembrolizumab in patients with recurrent or metastatic cervical cancer

OV21/PETROC: a randomized Gynecologic Cancer Intergroup phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer

631P Phase Ib expansion study of CX-5461 in patients with solid tumours and BRCA2 and/or PALB2 mutation

Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer

Association of PD-L1 expression and gene expression profiling with clinical response to pembrolizumab in patients with advanced recurrent ovarian cancer: Results from the phase II KEYNOTE-100 study

A randomized, double-blind, placebo-controlled multicenter phase 3 trial of niraparib maintenance treatment in patients with advanced ovarian cancer following frontline chemotherapy

Phase II multicenter open‐label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies

Quality of life in patients with recurrent ovarian cancer (OC) treated with niraparib: Results from the ENGOT-OV16/NOVA Trial

Safety and Efficacy of Niraparib in Elderly Patients (Pts) with Recurrent Ovarian Cancer (OC)

The contribution of germline rearrangements to the spectrum of BRCA2 mutations

Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes

Vers un dépistage possible du cancer de l’ovaire ?

Comparison of Antigen Expression on Fresh and Cultured Ascites Cells and on Solid Tumors of Patients with Epithelial Ovarian Cancer

Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer

Antigenic heterogeneity in epithelial ovarian (EOC) cancer

Comparison of antigenic expression on fresh ascitic epithelial cells (AEC), cultured AEC and solid tumors of patients with epithelial ovarian cancer (EOC)

Laparoscopic Radical Hysterectomy versus Abdominal Radical Hysterectomy: A Non-randomized Study

An assessment of microplastics in fecal samples from polar bears ( Ursus maritimus ) in Canada's North

Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe

833P Mirvetuximab soravtansine (MIRV), a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with carboplatin (CARBO) and bevacizumab (BEV): Final results from a study in patients (pts) with recurrent platinum sensitive ovarian cancer

Suchergebnisse filtern